Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

A new biotechnology firm, Pharma Technologies, has developed a competing method for the treatment of erectile dysfunction which promises significant advantages over Pfizer''s blockbuster drug, Viagra. With deep-pocketed pharmaceutical companies also pursuing product development efforts, the president of Pharma Technologies is charged with deciding how to leverage his company''s superior proprietary technology into a viable product before the window of opportunity closes. Students can explore the trade-offs is pursuing internal versus external development of new technology, the strategic implications of in-licensing and out-licensing, and the criteria used in identifying potential alliance partners to expedite the commercialization of new technology.
Location:
Size:
Small
Other setting(s):
1999

About

Abstract

A new biotechnology firm, Pharma Technologies, has developed a competing method for the treatment of erectile dysfunction which promises significant advantages over Pfizer''s blockbuster drug, Viagra. With deep-pocketed pharmaceutical companies also pursuing product development efforts, the president of Pharma Technologies is charged with deciding how to leverage his company''s superior proprietary technology into a viable product before the window of opportunity closes. Students can explore the trade-offs is pursuing internal versus external development of new technology, the strategic implications of in-licensing and out-licensing, and the criteria used in identifying potential alliance partners to expedite the commercialization of new technology.

Settings

Location:
Size:
Small
Other setting(s):
1999

Related